Front page

The UK’s £34.6bn medical research endowment warns of difficult period ahead for private equity, marked by subdued distributions and longer fundraising cycles.

Even amid a tougher fundraising environment, climate funds are 'still very, very topical', says head of sustainable investing for private markets Ken Pontarelli.

The asset class has changed markedly since Private Equity International first started reporting on it in 2001.

Zombie funds, LP substitutions and a dealmaking rebound could be on the cards for the Asia-Pacific private equity markets this year.

LPs had a massive number of private equity funds to consider over the past year – an ongoing dynamic that has caused headaches for those grappling with the denominator effect.

Several of PE's largest firms have made real strides in expanding access this year, though questions remain over whether individual investors are being adequately educated.

The cost of borrowing became more expensive in 2022, resulting in both challenges and opportunities for the industry.

Council members asked investment staff for more allocation options due to liquidity concerns.

While LP behaviour was heavily influenced by allocation limits this year, there are reasons for GPs to remain optimistic heading into 2023.

IPEV’s expanded guidelines aim to help sponsors with dislocation and distress.